Dose-interval study of a dual probiotic in preterm infants.
Claire WatkinsKiera MurphyEugene M DempseyCarol Anne O'SheaBrendan Paul MurphyPaul W O'TooleR Paul RossCatherine StantonAnthony C RyanPublished in: Archives of disease in childhood. Fetal and neonatal edition (2018)
Our results indicate that a daily dose of Infloran is a suitable dosage for preterm infants in the neonatal intensive care unit, with significantly higher levels of Bifidobacterium found in the daily probiotic group up to 44 weeks PMA.